CS Paper Radar

Safe Data-Driven Insulin Dosage Decision Based on Physiology-Constrained Gaussian Process Learning

Deheng Cai, Xiang Lu, Wei Liu, Jing Chen, Linong Ji, Dawei Shi

eess.SY ·submitted 2026-11-19 11:49 UTC · v1

Abstract

Multiple daily injections (MDI) therapy is widely adopted by insulin-treated subjects with diabetes mellitus. In this work, we study how to ensure that data-driven model learning is aligned with the underlying physiological principles, and introduce a safe data-driven learning and decision framework for the MDI therapy. To provide credible glucose predictions for the decision, a physiology-constrained Gaussian process learning method is developed for glycemic dynamics modeling by encoding the physiological priors as constraints in the model training. Considering the natural day-to-day cycle of insulin decisions, a prediction-based optimization formulation with an objective function that has a penalty term associated with the previous dosage is employed for the insulin therapy, together with the asymmetric penalties on hyper- and hypoglycemia for safety. The effectiveness of the proposed method is verified using the 10-adult cohort from the FDA-accepted UVA/Padova T1DM simulator, and an advisory mode analysis is also conducted based on the clinical data from 40 type 1 diabetes and 55 type 2 diabetes subjects to indicate the safe and physiologically plausible decisions in the real-life applications.

Closest papers

Nearest neighbours by meaning across the whole index.

Primal--Dual Alternating Neural Learning for Timely Classification with Performance Guarantees

cs.LG stat.MLstat.ME ·2026-08-24 ·Jiaming Qiu, Yingye Zheng, Ying-Qi Zhao
similarity 0.64
Abstract

Timely risk classification is essential in many clinical monitoring settings, where decisions must balance the benefit of classifying patients early for subsequent intervention against the value of observing additional data. Yet most existing statistical and machine-learning methods are designed for fully observed trajectories and offer limited control over key operating characteristics such as sensitivity, specificity, and monitoring cost. We cast the sequential classification problem within a multi-objective optimization framework targeting these three criteria. We characterize the optimal decision rule through a value recursion that quantifies, at each time point, the trade-off between immediate classification and continued monitoring. To estimate the rule from data, we formulate a constrained optimization problem that maximizes specificity while enforcing prespecified sensitivity and monitoring-cost constraints. We then develop an estimation procedure that employs a recurrent neural network to approximate the evolving value processes and a primal--dual updating scheme to satisfy the performance constraints. Through simulation studies and an application to continuous glucose monitoring for hypoglycemia risk prediction, we demonstrate that the proposed method yields accurate and timely sequential decision rules that adhere to the desired operating characteristics.

0.14

Evaluating Type-1 Diabetes Digital Twins by Decision Quality

cs.LG ·2026-10-22 ·Victor Li, Owen Tucker, Michael S. Hughes, Temiloluwa Prioleau, Shengpu Tang
code/data similarity 0.63
Abstract · 12 pages, 1 figure, 7 tables. Code: https://github.com/Veeeeeee7/T1D-Digital-Twin-Benchmark

A digital twin (DT) for type 1 diabetes (T1D) can predict how an individual's blood glucose will respond to different insulin treatments without actually trying them. For each treatment, downstream statistics of predicted glucose trajectories, such as glycemic risk, can be computed to guide clinical decisions. However, the quality of DTs is usually measured by the accuracy of their predicted glucose trajectories, which may not reflect the quality of the downstream treatment decisions they inform. In this work, we directly evaluate DTs by this decision quality on downstream treatment ranking, i.e., whether a DT predicts glucose trajectories that can be used to rank candidate treatments as the real patient would. We present an evaluation protocol over 30 virtual patients from the FDA-accepted UVA/Padova model, each simulated under 21 different basal-bolus treatments. For each patient, a DT is fitted under one treatment and then produces glucose trajectories for the remaining 20 treatments. Our results show that prediction accuracy and decision quality disagree. A baseline that models the average patient, never seeing the individual's glucose data, has the lowest prediction accuracy of all six methods (RMSE: 63.6 mg/dL) but ranks treatments with the second-highest mean Spearman (0.766), while a black-box neural network that predicts glucose nearly twice as accurately (RMSE: 32.9 mg/dL) ranks them no better than a random ordering of the 20 treatments (0.049 Spearman). Therefore, selecting a DT based on prediction accuracy alone can prefer one that recommends treatments at chance, and decision quality must be evaluated directly rather than assumed to follow from prediction accuracy.

0.34

Bayesian optimization on amortized search space

cs.LG stat.ML ·2026-11-19 ·Tristan Fauvel, Federico Pavone, Titouan Guillou, Pau Redon Muñoz, Chloé Geoffroy
similarity 0.61
Abstract

In real-world black-box optimization problems, a mechanistic simulator is often available that approximately predicts the behavior of the system as a function of the parameters being optimized. Here, we show how an amortized inverse map of such a simulator can be used in Bayesian optimization to restrict the search space while using a Gaussian process kernel that is aware of the original problem geometry. This allows for efficiently leveraging the low intrinsic dimensionality of the optimization problem. We characterize its approximation bias and information gain, and derive an intrinsic-dimension-dependent regret rate under additional geometric and Gaussian Process assumptions. We illustrate the method with an application to drug dosing personalization in Parkinson's disease. We use, as a simulator, a pharmacokinetic/pharmacodynamic (PK/PD) model of a drug, a mechanistic model calibrated on population data with quantified parameter uncertainty. A dosing neural network is trained offline against the model, amortizing the map from patient PK/PD parameters to the regimen predicted to be optimal, and online Bayesian optimization then searches over this learned, low-dimensional representation rather than over raw dosages. Numerical simulations demonstrate the improved performance of our method in this application, as well as under simulator misspecification.

0.24

SSMCGM-Stream: A Streaming State-Space Model for Personalized Diabetes Management

cs.LG cs.AI ·2026-10-20 ·Shakson Isaac, Chirag Patel
top venue similarity 0.60
Abstract · Accepted to AI4Science and GenAI4Health NeurIPS 2026 workshops

Continuous glucose monitoring supports diabetes management but requires forecasting models that are accurate, interpretable, and efficient enough for real-time deployment. We present SSMCGM-Stream, a streaming state-space model that maintains a personalized hidden state updated with each incoming glucose reading to provide constant-time forecasting, physiologically structured counterfactual reasoning, and interpretable forecasts through hidden-state attribution. Built on this foundation, SSMCGM-Agent delivers risk-aware, natural-language decision support by translating forecasts, explanations, and counterfactuals into grounded recommendations through a guarded language-model interface. Evaluated on the T1DEXI cohort, SSMCGM-Stream achieves forecasting performance comparable to strong neural baselines while substantially reducing computational cost, enabling continuous on-device diabetes decision support.

0.35

Sensitivity-driven Personalization of a Glucoregulatory Model for Digital Twin Therapeutics in Type 1 Diabetes

eess.SY ·2026-09-25 ·Clara Escorihuela-Altaba, Vihangkumar V. Naik, Eleonora Manzoni, Jose Garcia-Tirado
similarity 0.59
Abstract

Digital twins are increasingly used in diabetes research, but reproducing individual glucose dynamics requires accurate identification of glucoregulatory model parameters. Traditional sensitivity analysis can identify influential parameters, yet a ranking based on limited conditions may miss parameters that matter during specific disturbances or for particular individuals. We therefore examine both the magnitude and timing of parameter influence across dynamic input-output conditions and assess whether a common ranking holds across participants. We analyze the Hovorka glucoregulatory model using data from 192 participants receiving automated insulin delivery therapy in the Type 1 Diabetes and Exercise Initiative dataset. We extend Sobol sensitivity analysis to time series and rank parameter influence under four conditions: full-day profiles, isolated meal disturbances, insulin bolus injections, and postprandial responses. We combine the condition-specific results into a global ranking and use it to select parameters for participant-specific identification. Compared with population parameters, identification restricted to the sensitivity-derived subset reduces the root mean square error of 60-minute glucose predictions by 60%, to approximately 31 mg/dL. These findings suggest that a global ranking can capture parameter influence across individuals and dynamic conditions. By narrowing the parameters requiring identification, this approach reduces computational cost and could accelerate the development of personalized diabetes digital twins.

0.20

Beyond Binary Classification: Multiclass Machine Learning for Diabetes and Prediabetes Risk Prediction Using NHANES

cs.LG ·2026-11-12 ·Aman Mujahid, Anita Penkova
similarity 0.59
Abstract

Detecting diabetes risk early is important for preventing disease progression. Most existing machine learning approaches focus on binary classification, which limits their ability to capture intermediate risk states such as prediabetes. We develop a supervised learning framework to classify adults as normal, prediabetic, or diabetic using National Health and Nutrition Examination Survey data. The framework uses routinely collected demographic, clinical, and lifestyle variables from 15,356 adults, with glycated hemoglobin (HbA1c) used only to define labels and excluded from input features to prevent leakage. We compare conventional machine learning and transformer-based models and examine two binary formulations: normal versus prediabetes, and normal versus combined prediabetes and diabetes. Models are evaluated on a held-out test set using precision, sensitivity, specificity, and F1 score. In the multiclass setting, performance is broadly consistent across models, with accuracy up to 0.72 and macro-averaged F1 of 0.70. Prediabetes remains the most challenging class, with F1 scores of 0.54 to 0.56 for conventional models and 0.53 to 0.55 for transformers, reflecting its overlap with both neighboring states. When the task is reduced to normal versus prediabetes, F1 scores rise modestly to 0.62 to 0.64. A more substantial improvement is observed under a broader screening formulation combining prediabetes and diabetes, with F1 scores of 0.73 to 0.74 across all models. These findings suggest that feature overlap along the biological continuum between normal and diabetic states contributes more to the difficulty of prediabetes detection than model architecture. Multiclass prediction provides a more clinically informative representation of metabolic risk progression but highlights a trade-off between clinically meaningful stratification and predictive accuracy.

0.15

It's All in the Way You Say It: The Role of Information Representation in LLM-Based Glycemic-Event Prediction

cs.AI ·2026-09-08 ·Andrea Apicella, Pasquale Arpaia, Matteo Orefice, Andrea Pollastro, Roberto Prevete
similarity 0.58
Abstract · Submitted to a journal for peer-review

Large Language Models (LLMs) are increasingly being investigated for physiological time-series prediction, yet their effectiveness may depend not only on the model itself, but also on how physiological information is represented and presented at inference time. This study investigates prompt-based general-purpose LLMs for postprandial hyperglycemia and hypoglycemia prediction in individuals with type 1 diabetes. Using the OhioT1DM dataset, we evaluate multiple open-weight LLMs under zero-shot and few-shot inference across prediction horizons of 30, 60, and 90 minutes. The analysis varies both the textual representation of the available physiological information and the amount of information exposed to the model, ranging from glucose observations alone to derived descriptors and additional contextual variables related to insulin, meals, carbohydrates, and physical activity. Performance is compared with conventional patient-specific supervised models and with Gluco-LLM, a language-model-based architecture explicitly adapted to glucose time-series forecasting. Results show a marked task-dependent behavior. Conventional supervised models achieve the strongest performance for hyperglycemia prediction, whereas the best observed prompt-based LLM configurations improve performance for hypoglycemia across all investigated horizons. The effectiveness of prompt-based inference is also strongly influenced by how physiological information is represented, while providing additional contextual information does not lead to a systematic improvement. Overall, these findings highlight physiological information representation as a central design factor in prompt-based LLM approaches to glycemic-event prediction.

0.35

PMB-NN: Physiological-Model-Based Neural Network for Glucose Forecasting in Type 1 Diabetes

cs.LG physics.med-ph ·2026-10-11 ·Yaowen Zhang, Shuhao Que, Ying Wang
similarity 0.57
Abstract

Accurate, physiologically consistent glucose forecasts could help people with type 1 diabetes respond to impending excursions. We applied our physiological-model-based neural network (PMB--NN) framework to glucose forecasting. A temporal convolutional network (TCN) used 180 min of history, constrained during training by a personalized four-parameter physiological model. The main PMB--NN combined forecast and neural--physiological agreement losses; a three-term variant additionally fitted physiological predictions to measured glucose. Data comprised 6--8 weeks of continuous glucose monitoring, pump, and meal records from 25 AZT1D participants. Person-specific models used chronological 70/10/20 train/validation/test splits and 30-, 60-, and 120-min horizons. Median mean absolute errors were 16.24, 25.00, and 30.20 mg/dL with basal insulin records and 15.38, 24.21, and 31.79 mg/dL before these records became available. In the latter setting, PMB--NN had the lowest median error at 30 and 60 min; it outperformed the physiological model alone in all six settings. In input-increase tests, glucose predictions changed in the expected direction for 85\% of correction boluses and 100\% of carbohydrate rescues, versus 57\% for active insulin and 56\% for active carbohydrates. Most standalone physiological fits showed locally distinguishable parameter effects, with glucose-related coefficients more stable under resampling than insulin- or carbohydrate-related coefficients. The three-term variant improved hyperglycaemia accuracy with basal records, but did not significantly change overall MAE and reduced directional plausibility in three tests. PMB--NN combines personalized forecasting with an explicit physiological model, allowing assessment of predictive accuracy, physiological response behavior, and participant-specific coefficients.

0.15